Neuroimaging studies of subjects who are gene-expanded for Huntington Disease, but not yet diagnosed (termed prodromal HD), report that the cortex is "spared," despite the decrement in striatal and cerebral white-matter volume. Measurement of whole-cortex volume can mask more subtle, but potentially clinically relevant regional changes in volume, thinning, or surface area. The current study addressed this limitation by evaluating cortical morphology of 523 prodromal HD subjects. Participants included 693 individuals enrolled in the PREDICT-HD protocol. Of these participants, 523 carried the HD gene mutation (prodromal HD group); the remaining 170 were non gene-expanded and served as the comparison group. Based on age and CAG repeat length, gene-expanded subjects were categorized as "Far from onset," "Midway to onset," "Near onset," and "already diagnosed." MRI scans were processed using FreeSurfer. Cortical volume, thickness, and surface area were not significantly different between the Far from onset group and controls. However, beginning in the Midway to onset group, the cortex showed significant volume decrement, affecting most the posterior and superior cerebral regions. This pattern progressed when evaluating the groups further into the disease process. Areas that remained mostly unaffected included ventral and medial regions of the frontal and temporal cortex. Morphologic changes were mostly in thinning as surface area did not substantially change in most regions. Early in the course of HD, the cortex shows changes that are manifest as cortical thinning and are most robust in the posterior and superior regions of the cerebrum.
Introduction
Huntington disease (HD) is a neurodegenerative disorder that manifests in a triad of symptoms including cognitive, motor, and behavioral abnormalities. The discovery of the gene in 1993 (Huntingngton's Disease Collaborative Research Group, 1993) provided an opportunity to study individuals who carry the mutant gene, but have not yet manifested significant disease signs and are therefore referred to as prodromal HD.
HD is part of a family of poly-glutamine diseases in which the mutant gene (huntingtin in the case of HD) contains a triplet CAG repeat coding for an expanding polyglutamine repeat and resulting in an abnormal or toxic protein. Another property of polyglutamine diseases is that despite the fact that the mutant proteins are expressed ubiquitously, the disease manifestation is specific to brain tissue and also to specific regions of the brain. For HD, the area of the brain most affected is that of the striatum. Therefore, most of the studies of HD, using either neuropathologic methods or neuroimaging methods have focused on measuring the effects of the disease on this brain region. However, more recently, there have been a number of studies evaluating "extra-striatal" brain structure such as the morphology of the cerebral white matter and cortex in subjects with early HD or prodromal HD. As a whole, these studies support an interesting pattern in which the cerebral white matter volume Neurobiology of Disease 40 (2010) [544] [545] [546] [547] [548] [549] [550] [551] [552] [553] [554] 
